Large-Scale Characterization of DNA Methylation Changes in Human Gastric Carcinomas with and without Metastasis
Large-Scale Characterization of DNA Methylation Changes in Human Gastric Carcinomas with and without Metastasis
Abstract Purpose: Metastasis is the leading cause of death for gastric carcinoma. An epigenetic biomarker panel for predicting gastric carcinoma metastasis could have significant clinical impact on the care of patients with gastric carcinoma. The main purpose of this study is to characterize the methylation differences between gastric carcinomas with and without metastasis. Experimental Design: Genome-wide DNA methylation profiles between 4 metastatic and 4 nonmetastatic gastric carcinomas and their surgical margins (SM) were analyzed using methylated-CpG island amplification with microarray. The methylation states of 73 candidate genes were further analyzed in patients with gastric carcinoma in a discovery cohort (n = 108) using denatured high performance liquid chromatography, bisulfite-sequencing, and MethyLight. The predictive values of potential metastasis-methylation biomarkers were validated in cohorts of patients with gastric carcinoma in China (n = 330), Japan (n = 129), and Korea (n = 153). Results: The gastric carcinoma genome showed significantly higher proportions of hypomethylation in the promoter and exon-1 regions, as well as increased hypermethylation of intragenic fragments when compared with SMs. Significant differential methylation was validated in the CpG islands of 15 genes (P < 0.05) and confirmed using bisulfite sequencing. These genes included BMP3, BNIP3, CDKN2A, ECEL1, ELK1, GFRA1, HOXD10, KCNH1, PSMD10, PTPRT, SIGIRR, SRF, TBX5, TFPI2, and ZNF382. Methylation changes of GFRA1, SRF, and ZNF382 resulted in up- or downregulation of their transcription. Most importantly, the prevalence of GFRA1, SRF, and ZNF382 methylation alterations was consistently and coordinately associated with gastric carcinoma metastasis and the patients' overall survival throughout discovery and validation cohorts in China, Japan, and Korea. Conclusion: Methylation changes of GFRA1, SRF, and ZNF382 may be a potential biomarker set for prediction of gastric carcinoma metastasis. Clin Cancer Res; 20(17); 4598–612. ©2014 AACR.
- Institute of Science Tokyo Japan
- Augusta University United States
- Seoul National University Korea (Republic of)
- University System of Georgia United States
- New Generation University College Ethiopia
Adult, Male, China, Serum Response Factor, Glial Cell Line-Derived Neurotrophic Factor Receptors, Genome, Human, Carcinoma, DNA Methylation, Middle Aged, DNA-Binding Proteins, Gene Expression Regulation, Neoplastic, Stomach Neoplasms, Biomarkers, Tumor, Humans, Female, Neoplasm Metastasis, Promoter Regions, Genetic, Aged, Transcription Factors
Adult, Male, China, Serum Response Factor, Glial Cell Line-Derived Neurotrophic Factor Receptors, Genome, Human, Carcinoma, DNA Methylation, Middle Aged, DNA-Binding Proteins, Gene Expression Regulation, Neoplastic, Stomach Neoplasms, Biomarkers, Tumor, Humans, Female, Neoplasm Metastasis, Promoter Regions, Genetic, Aged, Transcription Factors
9 Research products, page 1 of 1
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2018IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).75 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
